Krebs Biochemicals & Industries Limited (BOM:524518)

BOM:524518 Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	-197.28	-246.92	-445.27	-283.59	-288.72
Depreciation & Amortization	65.83	63.75	56.58	48.64	44.19
Other Amortization	1.84	1.84	6.39	2.6	2.6
Other Operating Activities	51.18	32.59	51.14	65.52	42.71
Change in Accounts Receivable	-13.78	3.51	-5.77	-0.98	27.09
Change in Inventory	21.49	136.17	-89.62	-16.05	-60.32
Change in Accounts Payable	36.89	-226.26	171.3	-18.71	12.55
Change in Other Net Operating Assets	56.88	-11.81	83.09	56.82	-135.08
Operating Cash Flow	23.04	-247.13	-172.16	-145.75	-354.98
Capital Expenditures	-94.15	-151.58	-270.78	-255.06	-94.11
Other Investing Activities	15.98	25.13	41.79	29.57	-8.11
Investing Cash Flow	-78.17	-126.45	-229	-225.49	-102.22
Long-Term Debt Issued	102.54	403.17	323.84	334.91	150.67
Total Debt Issued	102.54	403.17	323.84	334.91	150.67
Net Debt Issued (Repaid)	102.54	403.17	323.84	334.91	150.67
Issuance of Common Stock	-	-	125.13	104.49	194.36
Other Financing Activities	-46.89	-29.73	-53.91	-62.79	-59.28
Financing Cash Flow	55.64	373.43	395.06	376.61	285.75
Miscellaneous Cash Flow Adjustments	0	0	-	-	-
Net Cash Flow	0.52	-0.15	-6.1	5.36	-171.45
Free Cash Flow	-71.11	-398.71	-442.95	-400.81	-449.09
Free Cash Flow Margin	-14.10%	-76.48%	-74.19%	-76.08%	-138.63%
Free Cash Flow Per Share	-3.30	-18.49	-20.54	-20.43	-24.95
Cash Interest Paid	46.86	29.71	53.85	62.72	59.24
Levered Free Cash Flow	-37.27	-336.06	-332.22	-449.94	-372.53
Unlevered Free Cash Flow	-7.98	-317.49	-298.57	-410.75	-335.04
Change in Net Working Capital	-113.47	94.96	-156.08	68.47	143.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.